Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iBio (IBIO) Return on Sales (2016 - 2025)

iBio (IBIO) has disclosed Return on Sales for 16 consecutive years, with 82.46% as the latest value for Q4 2025.

  • On a quarterly basis, Return on Sales fell 6064.0% to 82.46% in Q4 2025 year-over-year; TTM through Dec 2025 was 82.46%, a 4666.0% decrease, with the full-year FY2025 number at 45.94%, down 388.0% from a year prior.
  • Return on Sales was 82.46% for Q4 2025 at iBio, down from 57.2% in the prior quarter.
  • In the past five years, Return on Sales ranged from a high of 3.14% in Q1 2022 to a low of 130.22% in Q4 2023.
  • A 5-year average of 41.43% and a median of 25.66% in 2022 define the central range for Return on Sales.
  • Peak YoY movement for Return on Sales: crashed -10472bps in 2023, then surged 10840bps in 2024.
  • iBio's Return on Sales stood at 19.01% in 2021, then plummeted by -34bps to 25.5% in 2022, then crashed by -411bps to 130.22% in 2023, then surged by 83bps to 21.82% in 2024, then tumbled by -278bps to 82.46% in 2025.
  • Per Business Quant, the three most recent readings for IBIO's Return on Sales are 82.46% (Q4 2025), 57.2% (Q3 2025), and 25.82% (Q2 2025).